Dr. med. Simon Hirschmann



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial. (2024) Atreya R, Kühbacher T, Waldner M, Hirschmann S, Drvarov O, Abu Hashem R, Maaser C, et al. Journal article Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn’s disease patient upon infliximab-induced lupus-like syndrome (2021) Hirschmann S, Fischer S, Klenske E, Dechant K, Distler J, Treutlein C, Neurath M, Atreya R Journal article Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab (2021) Fischer S, Cohnen S, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Journal article Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study (2020) Allner C, Melde M, Becker E, Fuchs F, Mühl L, Klenske E, Müller L, et al. Journal article Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy (2020) Ganzleben I, Hirschmann S, Köhler J, Fuchs F, Rieker R, Baer E, Klenske E, et al. Journal article Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis (2020) Ganzleben I, Geppert CI, Osaba L, Hirschmann S, Nägel A, Glück C, Hoffman A, et al. Journal article Efficacy, safety, and pharmacokinetics after switching from infliximab originator to biosimilar SB2 in inflammatory bowel disease patients: A long-term observational, prospective cohort study (2020) Fischer S, Mesfin SE, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Conference contribution Magnification endoscopy with optical chromoendoscopy shows strong correlation with histologic inflammation in patients with inflammatory bowel disease (2019) Klenske E, Atreya R, Hartmann A, Fischer S, Hirschmann S, Zundler S, Iaccuci M, et al. Journal article Addiction in IBD patients: more than just smoke? (2019) Hirschmann S, Koehnen J, Schuster B, Atreya R, Krauss N, Mudter J, Dauer M, et al. Conference contribution Magnification endoscopy with optical chromoendoscopy for in vivo assessment of histological inflammation in patients with inflammatory bowel disease (2019) Klenske E, Atreya R, Hartmann A, Fischer S, Hirschmann S, Zundler S, Iacucci M, et al. Conference contribution